Sreoshi Chatterjee 452 posts 0 comments

When compared to medical therapies, a bariatric surgeon and an endocrinologist specializing in diabetes observed that the effectiveness of medical versus surgical intervention proved to…
Read More...

Intec Pharma asserted that it has partnered with LTS Lohmann Therapie-Systeme AG for manufacturing Company's lead candidate, Accordion Pill Carbidopa/Levodopa (AP-CD/LD) as a treatment…
Read More...

As far as an article published in Experimental Biology and Medicine is concerned, Experimental Biology and Medicine ascertains a new pathway that contributes to lung failure in patients…
Read More...

Paramount comprehensive liquid biopsy, Guardant360 assay to be utilized as sole liquid biopsy in LC-SCRUM-Japan which is a nationwide genomic screening network run by the National…
Read More...

Malachite Management asserted that it has recently been granted accreditation by Association Management Company Institute (AMCI), the global trade association representing the…
Read More...

MiNA Therapeutics announced the publication of pre-clinical data on its MTL-CEBPA program in which the compound was shown to promote disease reversal in several models of liver disease…
Read More...

Pfizer declared optimistic outcome from U.S FDA's Gastrointestinal Drugs Advisory Committee (GIDAC) meeting.  The  GIDAC met to discuss Pfizer’s supplemental New Drug Application (sNDA…
Read More...

In a bid to expand its premium Cardiovascular ultrasound system that delivers a complete solution for structural heart analysis, Canon Medical Systems USA has introduced a new version…
Read More...

MiMedx Group which is a leading developer and marketer of regenerative and therapeutic biologics asserted that the U.S Food and Drug Administration has extended MiMedx's micronized…
Read More...

CTI BioPharma Corp asserted that results from the Phase 3 PERSIST-2 clinical Trial of pacritinib which is an investigational JAK22 inhibitor that has been published online in JAMA…
Read More...